Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

123I-MIBG for detection of subacute doxorubicin-induced cardiotoxicity in patients with malignant lymphoma.

Laursen AH, Ripa RS, Hasbak P, Kjær A, Elming MB, Køber L, Hutchings M, Thune JJ.

J Nucl Cardiol. 2018 Dec 19. doi: 10.1007/s12350-018-01566-y. [Epub ahead of print]

PMID:
30569409
2.

Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy.

Valdés Olmos RA, ten Bokkel Huinink WW, ten Hoeve RF, van Tinteren H, Bruning PF, van Vlies B, Hoefnagel CA.

Eur J Cancer. 1995;31A(1):26-31.

PMID:
7695974
3.

Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity?

Guimarães SL, Brandão SC, Andrade LR, Maia RJ, Markman Filho B.

Arq Bras Cardiol. 2015 Sep;105(3):228-34. doi: 10.5935/abc.20150075. Epub 2015 Jul 3. English, Portuguese.

4.

Doxorubicin-induced cardiac neurotoxicity: study with iodine 123-labeled metaiodobenzylguanidine scintigraphy.

Lekakis J, Prassopoulos V, Athanassiadis P, Kostamis P, Moulopoulos S.

J Nucl Cardiol. 1996 Jan-Feb;3(1):37-41.

PMID:
8799226
5.

I-123 MIBG and serial radionuclide angiocardiography in doxorubicin-related cardiotoxicity.

Valdés Olmos RA, ten Bokkel Huinink WW, Greve JC, Hoefnagel CA.

Clin Nucl Med. 1992 Mar;17(3):163-7.

PMID:
1611784
6.

123 I-MIBG imaging for detection of anthracycline-induced cardiomyopathy.

Laursen AH, Thune JJ, Hutchings M, Hasbak P, Kjaer A, Elming MB, Ripa RS.

Clin Physiol Funct Imaging. 2018 Mar;38(2):176-185. doi: 10.1111/cpf.12419. Epub 2017 Mar 2. Review.

PMID:
28251781
8.

Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity.

Carrió I, Estorch M, Berná L, López-Pousa J, Tabernero J, Torres G.

J Nucl Med. 1995 Nov;36(11):2044-9.

9.

I-123-MIBG myocardial imaging in trastuzumab-based cardiotoxicity: the first experience.

Stokkel MP, de Wit-van der Veen LJ, Boekhout A.

Nucl Med Commun. 2013 Jan;34(1):19-24. doi: 10.1097/MNM.0b013e32835ae523.

PMID:
23111379
10.

ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.

Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H.

J Nucl Med. 1997 Jul;38(7):1085-9.

11.

(123)I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy.

Christensen TE, Bang LE, Holmvang L, Skovgaard DC, Oturai DB, Søholm H, Thomsen JH, Andersson HB, Ghotbi AA, Ihlemann N, Kjaer A, Hasbak P.

JACC Cardiovasc Imaging. 2016 Aug;9(8):982-90. doi: 10.1016/j.jcmg.2016.01.028. Epub 2016 Jun 22.

12.

Assessment of late anthracycline-induced cardiotoxicity by 123I-mIBG cardiac scintigraphy in patients treated during childhood and adolescence.

Dos Santos MJ, da Rocha ET, Verberne HJ, da Silva ET, Aragon DC, Junior JS.

J Nucl Cardiol. 2017 Feb;24(1):256-264. doi: 10.1007/s12350-015-0309-y. Epub 2015 Nov 24.

PMID:
26601670
14.

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, Shimamoto K.

J Nucl Med. 2001 Dec;42(12):1757-67.

15.

Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.

Pace L, Betocchi S, Losi MA, Della Morte AM, Ciampi Q, Nugnez R, Chiariello M, Salvatore M.

Q J Nucl Med Mol Imaging. 2004 Mar;48(1):20-5.

16.

Noninvasive identification of anthracycline cardiotoxicity: comparison of 123I-MIBG and 123I-BMIPP imaging.

Takeishi Y, Sukekawa H, Sakurai T, Saito H, Nishimura S, Shibu T, Sasaki Y, Tomoike H.

Ann Nucl Med. 1994 Aug;8(3):177-82.

PMID:
7811559
17.

Iodine-123 metaiodobenzylguanidine in the assessment of late cardiac effects from cancer therapy.

Valdés Olmos RA, ten Bokkel Huinink WW, Dewit LG, Hoefnagel CA, Liem IH, van Tinteren H.

Eur J Nucl Med. 1996 Apr;23(4):453-8.

PMID:
8612668
18.

Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.

Bulten BF, Verberne HJ, Bellersen L, Oyen WJ, Sabaté-Llobera A, Mavinkurve-Groothuis AM, Kapusta L, van Laarhoven HW, de Geus-Oei LF.

Cancer Chemother Pharmacol. 2015 Nov;76(5):957-67. doi: 10.1007/s00280-015-2874-9. Epub 2015 Sep 23.

19.

Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.

Maunoury C, Acar P, Sidi D.

Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1651-6. Epub 2003 Sep 23.

PMID:
14504829
20.

Supplemental Content

Support Center